Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Jacobio Pharmaceuticals Group Co., Ltd. ( (HK:1167) ) is now available.
Jacobio Pharmaceuticals Group Co., Ltd. has announced a board meeting scheduled for August 29, 2025, to consider and approve the interim results for the first half of the year. This meeting is significant as it will address the company’s financial performance and potentially influence its strategic direction and stakeholder interests.
The most recent analyst rating on (HK:1167) stock is a Hold with a HK$3.70 price target. To see the full list of analyst forecasts on Jacobio Pharmaceuticals Group Co., Ltd. stock, see the HK:1167 Stock Forecast page.
More about Jacobio Pharmaceuticals Group Co., Ltd.
Jacobio Pharmaceuticals Group Co., Ltd. is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. The company focuses on developing innovative pharmaceutical products and services, with a market emphasis on advancing healthcare solutions.
Average Trading Volume: 7,983,559
Technical Sentiment Signal: Buy
Current Market Cap: HK$6.78B
See more data about 1167 stock on TipRanks’ Stock Analysis page.